Company intelligence / Profile preview
Elevant
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
Overview
Elevant is a science-based health company specializing in cellular longevity and the restoration of NAD+ levels. Operating as a brand under the Swiss biotechnology firm Seneque, Elevant produces NMN-C, a proprietary and highly stable form of Nicotinamide Mononucleotide. The company distinguishes itself through a fully integrated supply chain and a commitment to clinical research, having initiated several human trials to evaluate the impact of NMN on energy, immunity, and organ health. Their products are designed to support the body's natural repair mechanisms and counteract the age-related decline of essential coenzymes.
- Therapeutic areas
- ImmunologyNeurologyOtherMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Elevant.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elevant.